Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliott Antman

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|May 15, 2012
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicineElliott Antman, Scott Weiss, Joseph Loscalzo
Pacing and Clinical Electrophysiology : PACE|July 24, 2012
Acute hyperkalemia detected by alert from implantable cardioverter-defibrillatorVikas Kuriachan, Usha Tedrow, Elliott Antman, et al.
Circulation|December 23, 2009
Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38Elizabeth M Mahoney, Kaijun Wang, Suzanne V Arnold, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 24, 2016
The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic SubstudyDeepak K Gupta, Robert P Giugliano, Christian T Ruff, et al.
JAMA Internal Medicine|December 9, 2014
Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data RegistryAmit N Vora, DaJuanicia N Holmes, Ivan Rokos, et al.
Circulation|April 12, 2021
Nonprofit Advocacy at the American Heart Association: Creating a Visionary Way Forward at Our 40th Anniversary: An American Heart Association Policy StatementKeith Churchwell, Elliott Antman, Jill Birnbaum, et al.
European Heart Journal|April 5, 2007
Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trialChadwick D Miller, Anindita Banerjee, Kenneth W Mahaffey, et al.
JAMA|November 24, 2005
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trialKenneth W Mahaffey, Marc Cohen, Jyotsna Garg, et al.
International Journal of Cardiology|May 2, 2009
Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGYSarah A Spinler, Kenneth W Mahaffey, Dianne Gallup, et al.
Current Nutrition Reports|February 15, 2022
Sodium and Health: Old Myths and a Controversy Based on DenialFrancesco P Cappuccio, Norm R C Campbell, Feng J He, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|May 15, 2012
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicineElliott Antman, Scott Weiss, Joseph Loscalzo
Pacing and Clinical Electrophysiology : PACE|July 24, 2012
Acute hyperkalemia detected by alert from implantable cardioverter-defibrillatorVikas Kuriachan, Usha Tedrow, Elliott Antman, et al.
Circulation|December 23, 2009
Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38Elizabeth M Mahoney, Kaijun Wang, Suzanne V Arnold, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 24, 2016
The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic SubstudyDeepak K Gupta, Robert P Giugliano, Christian T Ruff, et al.
JAMA Internal Medicine|December 9, 2014
Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data RegistryAmit N Vora, DaJuanicia N Holmes, Ivan Rokos, et al.
Circulation|April 12, 2021
Nonprofit Advocacy at the American Heart Association: Creating a Visionary Way Forward at Our 40th Anniversary: An American Heart Association Policy StatementKeith Churchwell, Elliott Antman, Jill Birnbaum, et al.
European Heart Journal|April 5, 2007
Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trialChadwick D Miller, Anindita Banerjee, Kenneth W Mahaffey, et al.
JAMA|November 24, 2005
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trialKenneth W Mahaffey, Marc Cohen, Jyotsna Garg, et al.
International Journal of Cardiology|May 2, 2009
Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGYSarah A Spinler, Kenneth W Mahaffey, Dianne Gallup, et al.
Current Nutrition Reports|February 15, 2022
Sodium and Health: Old Myths and a Controversy Based on DenialFrancesco P Cappuccio, Norm R C Campbell, Feng J He, et al.
Pageof 1